Patent · US Active

Anti- α5 β1 antibodies and uses thereof

US8124740B2 · kind B2 · utility

1Cited by
16References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 23, 2010
Grant dateFeb 28, 2012
Priority date
Expiry dateMay 1, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides new anti-α5β1 antibodies, compositions and kits comprising the antibodies, and methods of making and using the antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.